DB00039 | Palifermin | approved | yes | agonistbinder | Details |
DB02491 | 4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine | experimental | unknown | | Details |
DB02058 | 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone | experimental | unknown | | Details |
DB08896 | Regorafenib | approved | yes | inhibitor | Details |
DB08901 | Ponatinib | approved, investigational | unknown | inhibitor | Details |
DB09078 | Lenvatinib | approved, investigational | yes | inhibitor | Details |
DB09079 | Nintedanib | approved | yes | inhibitor | Details |
DB01901 | Sucrosofate | experimental | unknown | ligand | Details |
DB01109 | Heparin | approved, investigational | unknown | | Details |
DB10770 | Foreskin fibroblast (neonatal) | approved | unknown | agonist | Details |
DB10772 | Foreskin keratinocyte (neonatal) | approved | unknown | agonist | Details |
DB12010 | Fostamatinib | approved, investigational | unknown | inhibitor | Details |
DB12147 | Erdafitinib | approved, investigational | yes | inhibitor | Details |
DB15102 | Pemigatinib | approved, investigational | yes | inhibitor | Details |
DB15685 | Selpercatinib | approved, investigational | unknown | inhibitor | Details |
DB15822 | Pralsetinib | approved, investigational | unknown | inhibitor | Details |
DB11886 | Infigratinib | approved, investigational | yes | inhibitor | Details |
DB15149 | Futibatinib | approved, investigational | yes | inhibitor | Details |
DB17587 | KIN-3248 | investigational | yes | inhibitor | Details |